• Press Release

A to Z of Robotics: Dr. David Samadi Discusses: “Robotic Surgery Expert Emphasizes Significance of Experience for a Successful Surgery”

  • New York, NY
  • (September 30, 2011)

Dr. David Samadi, who serves as Chief of Robotics and Minimally Invasive Surgery and Vice Chairman of Department of Urology at The Mount Sinai Medical Center, hopes that robotic surgery is the ideal process to treat prostate cancer but he emphasized that experience is important. Dr. Samadi explained that both robotic and laparoscopic procedures have more benefits over open surgery. Improved visibility and minute incisions offered clear visuals of the cancer site and facilitated the removal of the prostate via a more hygienic surgical field, he said. Learn more


About the Mount Sinai Health System

Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.

As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.

Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.